Structure of a cannabinoid receptor and functional expression of the cloned cDNA
The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner. Although CNS depression and analgesia are well documented effects of the cannabinoids, the mechanisms responsible for these and other cannabinoid-induced effects are not so far known. The hydrophobic nature of these substances has suggested that cannabinoids resemble anaesthetic agents in their action, that is, they nonspecifically disrupt cellular membranes. Recent evidence, however, has supported a mechanism involving a G protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids. Here we report the cloning and expression of a complementary DNA that encodes a G protein-coupled receptor with all of these properties. Its messenger RNA is found in cell lines and regions of the brain that have cannabinoid receptors. These findings suggest that this protein is involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary psychoactive constituent of cannabis, THC (Mechoulam and Gaoni, 1965), and certain other plant-derived or synthetic psychoactive cannabinoids bind cannabinoid (CB 1 and CB 2 ) receptors (Devane et al, 1988;Matsuda et al, 1990;Munro et al, 1993).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Matsuda et al, 1990
In the citing paper
“Cannabinoids, like many analgesics and recreational drugs, act on the brain’s reward pathways. Cannabinoid-1 receptors (CB1R) are co-localized with the opioid receptors on the dopaminergic cells of the nucleus accumbens, probably the most important structure in human reward pathways, which partly overlaps the antinociceptive pathways [30–32].”
From Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial (2012) · cites this paper as [30]
In the citing paper
“Both CB12 and CB23 receptors are G-coupled protein receptors that are negatively coupled to adenylate cyclase.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [2]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
G proteins and dual control of adenylate cyclase
Gilman, A. G. (1984) · Cell · doi:10.1016/0092-8674(84)90336-2 · Cited by 1,802
Identification of a Family of Muscarinic Acetylcholine Receptor Genes
Bonner, T. I., Buckley, N. J., Young, A. C., & Brann, M. R. (1987) · Science · doi:10.1126/science.3037705 · Cited by 1,427
Self-citationA cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.
Okayama, H., & Berg, P. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.2.280 · Cited by 933
Lutropin-Choriogonadotropin Receptor: An Unusual Member of the G Protein-Coupled Receptor Family
McFarland, K. C., Sprengel, R., Phillips, H. S., Köhler, M., Rosemblit, N., Nikolics, K., Segaloff, D. L., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2502842 · Cited by 929
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Self-citationcDNA eloping of bovine substance-K receptor through oocyte expression system
Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., & Nakanishi, S. (1987) · Nature · doi:10.1038/329836a0 · Cited by 742
Cloning and Sequencing of Porcine LH-hCG Receptor cDNA: Variants Lacking Transmembrane Domain
Loosfelt, H., Misrahi, M., Atger, M., Salesse, R., Vu Hai-Luu Thi, M. T., Jolivet, A., Guiochon-Mantel, A., Sar, S., Jallal, B., Garnier, J., et al. (1989) · Science · doi:10.1126/science.2502844 · Cited by 559
Research works printed but not linked: 14
- Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
- Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
- Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
- Howlett, A. C. Molec. Pharmacol. 27, 429–436 (1985).
- Howlett, A. C. & Fleming, R. M. Molec. Pharmacol. 26, 532–538 (1984).
- Howlett, A. C., Qualy, J. M. & Khachatrian, L. L. Molec. Pharmacol. 29, 307–313 (1986).
- Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
- Howlett, A. C., Johnson, M. R., Melvin, L. S. & Milne, G. M. Molec. Pharmacol. 33, 297–302 (1988).
- Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
- Lawrence, D. K. & Gill, E. W. Molec. Pharmacol. 11, 595–602 (1975).
- Hillard, C. J., Harris, R. A. & Bloom, A. S. J. Pharmac. exp. Ther. 232, 579–588 (1985).
- Okayama, H. & Berg, P. Molec. cell. Biol. 3, 280–289 (1983).
- Chen, C. & Okayama, H. Molec. cell. Biol. 7, 2745–2752 (1987).
- Brooker, G., Harper, J. F., Terasaki, W. L. & Moylan, R. D. Adv. Cyclic Nucleotide Res. 10, 1–33 (1979).
Cited by
Items 901–1,000 of 1,050
Pavón, F. J., Bilbao, A., Hernández‐Folgado, L., Cippitelli, A., Jagerovic, N., Abellán, G., Rodríguez-Franco, M. I., Serrano, A., Macías, M., de Heras, R. G., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.029 · Cited by 124
Kehl, L. J., Hamamoto, D. T., Wacnik, P. W., Croft, D. L., Norsted, B. D., Wilcox, G. L., & Simone, D. A. (2003) · Pain · doi:10.1016/s0304-3959(02)00450-5 · Cited by 115
Marzo, V. D. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.01.010 · Cited by 140
The role of the CB1 receptor in the regulation of sleep
Murillo‐Rodríguez, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.04.008 · Cited by 121
The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats
Izzo, A. A., Mascolo, N., Pinto, L., Capasso, R., & Capasso, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00673-1 · Cited by 115
CNR1 Variation Modulates Risk for Drug and Alcohol Dependence
Zuo, L., Kranzler, H. R., Luο, X., Covault, J., & Gelernter, J. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.004 · Cited by 121
Rinaldi, M. L., Barth, F., Congy, C., Martinez, S., Oustric, D., Perio, A., Poncelet, M., Maruani, J., Arnone, M., Finance, O., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067884 · Cited by 115
Leroy, S., Griffon, N., Bourdel, M. C., Olié, J. P., Poirier, M. F., & Krebs, M. O. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10038 · Cited by 114
Bouaboula, M., Desnoyer, N., Carayon, P., Combes, T., & Casellas, P. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12171-2 · Cited by 115
Cannabinoid‐Induced Tetrad in Mice
Metna‐Laurent, M., Mondésir, M., Grel, A., Vallée, M., & Piazza, P. (2017) · Current Protocols in Neuroscience · doi:10.1002/cpns.31 · Cited by 134
Brain activity of anandamide: a rewarding bliss?
Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 125
Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
Gonçalves, E. C. D., Baldasso, G. M., Bicca, M. A., Paes, R. S., Capasso, R., & Dutra, R. C. (2020) · Molecules · doi:10.3390/molecules25071567 · Cited by 129
Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats
Sanson, M., Bueno, L., & Fioramonti, J. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00819.x · Cited by 111
Muccioli, G. G., Fazio, N., Scriba, G. K. E., Poppitz, W., Cannata, F., Poupaert, J. H., Wouters, J., & Lambert, D. M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050977k · Cited by 126
Marijuana and Medicine: Assessing the Science Base
Institute of Medicine (1999) · National Academies Press eBooks · doi:10.17226/6376 · Cited by 270
Cannabinoid-induced antinociception is mediated by a spinalα2-noradrenergic mechanism
Lichtman, A. H., & Martin, B. R. (1991) · Brain Research · doi:10.1016/0006-8993(91)90017-p · Cited by 114
Pharmacological Agents Affecting Emesis: A Review (Part II)
Mitchelson, F. J. (1992) · Drugs · doi:10.2165/00003495-199243040-00003 · Cited by 123
Kempe, K., Hsu, F.-F., Bohrer, A., & Turk, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17287 · Cited by 114
Chapter 15 Anandamide and the Vanilloid Receptor (TRPV1)
Tóth, A., Blumberg, P. M., & Boczán, J. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81015-7 · Cited by 114
Paria, B. C., Ma, W., Andrenyak, D. M., Schmid, P. C., Schmid, H. H. O., Moody, D. E., Deng, H., Makriyannis, A., & Dey, S. K. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.6.1490 · Cited by 113
Behavioural consequences of maternal exposure to natural cannabinoids in rats
Navarro, M. A., Rubio, P., & de Fonseca, F. R. (1995) · Psychopharmacology · doi:10.1007/bf02246436 · Cited by 124
Moreira, F. A., de Aguiar, D. C., Terzian, A. L. B., Guimarães, F. S., & Wotjak, C. T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.046 · Cited by 127
Nakata, M., & Yada, T. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.009 · Cited by 114
Neurochemical basis of cannabis addiction
Maldonado, R. J., Berrendero, F., Ozaita, A., & Robledo, P. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.035 · Cited by 137
Lambert, D. M., DiPaolo, F. G., Sonveaux, P., Kanyonyo, M. R., Govaerts, S. J., Hermans, E., Bueb, J., Delzenne, N. M., & Tschirhart, E. J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00132-8 · Cited by 113
Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
Mallat, A., & Lotersztajn, S. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00467.2007 · Cited by 110
Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor
Hudson, B. D., Hébert, T. E., & Kelly, M. E. M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060251 · Cited by 124
Synthetic Pot: Not Your Grandfather’s Marijuana
Ford, B. M., Tai, S., Fantegrossi, W. E., & Prather, P. L. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.003 · Cited by 122
Marijuana Use in Pregnancy: A Review
Thompson, R., DeJong, K. N., & Lo, J. O.-T. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000685 · Cited by 126
The role of endocannabinoids in pain modulation
Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12008 · Cited by 126
Nackley, A. G., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00886.2003 · Cited by 111
Mestre, L., Docagne, F., Correa, F., Loría, F., Hernangómez, M., Borrell, J. I., & Guaza, C. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.10.015 · Cited by 127
Davis, M. I., Ronesi, J., & Lovinger, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305697200 · Cited by 105
Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A
Cunningham, C. W., Rothman, R. B., & Prisinzano, T. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003244 · Cited by 123
Esfandyari, T., Camilleri, M., Busciglio, I., Burton, D., Baxter, K., & Zinsmeister, A. R. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00565.2006 · Cited by 110
Spagnolo, P. A., Ramchandani, V. A., Schwandt, M. L., Kwako, L. E., George, D. T., Mayo, L. M., Hillard, C. J., & Heilig, M. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13210 · Cited by 104
Valverde, O., Ledent, C., Beslot, F., Parmentier, M., & Roques, B. P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00929.x · Cited by 111
Orio, L., Edwards, S., George, O., Parsons, L. H., & Koob, G. F. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0563-09.2009 · Cited by 109
Gallelli, C. A., Calcagnini, S., Romano, A., Koczwara, J. B., de Ceglia, M., Dante, D., Villani, R., Giudetti, A. M., Cassano, T., & Gaetani, S. (2018) · Antioxidants · doi:10.3390/antiox7070093 · Cited by 122
Use of cannabidiol (CBD) for the treatment of chronic pain
Urits, I., Gress, K. L., Charipova, K., Habib, K., Lee, D. M., Lee, C. S., Jung, J. W., Kassem, H., Cornett, E. M., Paladini, A., et al. (2020) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2020.06.004 · Cited by 150
Neuroinflammation, Its Role in Alzheimer's Disease and Therapeutic Strategies
Király, M., Foss, J. F., & Giordano, T. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.109 · Cited by 121
Dissecting the cannabinergic control of behavior: The where matters
Busquets‐Garcia, A., Desprez, T., Metna‐Laurent, M., Bellocchio, L., Marsicano, G., & Soria‐Gomez, E. (2015) · BioEssays · doi:10.1002/bies.201500046 · Cited by 100
Horti, A. G., Gao, Y., Ravert, H. T., Finley, P. A., Valentine, H., Wong, D. F., Endres, C. J., Savonenko, A. V., & Dannals, R. F. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.058 · Cited by 121
Nestor, L., Roberts, G., Garavan, H., & Hester, R. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.059 · Cited by 104
A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling
Labar, G., Wouters, J., & Lambert, D. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791859414 · Cited by 111
Contassot, E., Tenan, M., Schnüriger, V., Pelte, M., & Dietrich, P. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.040 · Cited by 111
Cardiovascular actions of cannabinoids and their generation during shock
Wagner, J. A., Varga, K. R., & Kunos, G. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050287 · Cited by 119
Selley, D. E., Stark, S., Sim, L. J., & Childers, S. R. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00347-5 · Cited by 111
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 116
Meng, Q., Buchanan, B., Zuccolo, J., Poulin, M.-M., Gabriele, J. P., & Baranowski, D. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196396 · Cited by 116
Molecular Mechanism and Cannabinoid Pharmacology
Schurman, L. D., Lu, D., Kendall, D. A., Howlett, A. C., & Lichtman, A. H. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_298 · Cited by 133
Maia, J. C., FONSECA, B. K. S., Teixeira, N. A. A., & Correia‐da‐Silva, G. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa005 · Cited by 120
Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia
Akopian, A. N., Ruparel, N. B., Jeske, N. A., Patwardhan, A., & Hargreaves, K. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.008 · Cited by 110
Cannabinoids and PPARα signalling
Sun, Y., Alexander, S. P. H., Kendall, D. A., & Bennett, A. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341095 · Cited by 109
Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 115
Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors
Gareau, Y., Dufresne, C., Gallant, M., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N. M., WEECH, P. K., Metters, K. M., & Labelle, M. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00573-c · Cited by 110
Tsou, K., Lowitz, K., Hohmann, A. G., Martin, W. J., Hathaway, C. B., Bereiter, D. A., & Walker, J. M. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)83015-6 · Cited by 110
Cannabinoids modulate pain by multiple mechanisms of action
Richardson, J. D. (2000) · The Journal of Pain · doi:10.1016/s1526-5900(00)90082-8 · Cited by 109
Cannabis: a multifaceted plant with endless potentials
Fordjour, E., Manful, C. F., Sey, A. A., Javed, R., Pham, T. H., Thomas, R., & Cheema, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1200269 · Cited by 127
Bedse, G., Romano, A., Lavecchia, A. M., Cassano, T., & Gaetani, S. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141635 · Cited by 102
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and β‐cells
Matias, I., Gonthier, M., Petrosino, S., Docimo, L., Capasso, R., Hoareau, L., Monteleone, P., Roche, R., Izzo, A. A., & Di Marzo, V (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707424 · Cited by 104
Expression of cannabinoid CB 1 receptor mRNA in basal ganglia of normal and parkinsonian human brain
Hurley, M. J., Mash, D. C., & Jenner, P. G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0033-7 · Cited by 109
New mechanisms and perspectives in nicotine withdrawal
Jackson, K. J., Muldoon, P. P., De Biasi, M., & Damaj, M. I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.009 · Cited by 104
Oka, S., Ikeda, S., Kishimoto, S., Gokoh, M., Shin, Y., Waku, K., & Sugiura, T. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404252 · Cited by 109
Cannabinoids and Neuroprotection
Beltramo, M., Grundy, R. I., & Rabuffetti, M. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:029 · Cited by 121
Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid
Hillard, C. J., & Campbell, W. B. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30024-9 · Cited by 108
Basavarajappa, B. S., Ninan, I., & Arancio, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05685.x · Cited by 107
Li, C., Jones, P. M., & Persaud, S. J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.006 · Cited by 112
Endocannabinoid System: Chemical Characteristics and Biological Activity
Rezende, B., Alencar, A. K. N., de Bem, G. F., Fontes-Dantas, F. L., & Montes, G. C. (2023) · Pharmaceuticals · doi:10.3390/ph16020148 · Cited by 121
Lever, I. J., & Rice, A. S. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_10 · Cited by 115
Foll, B. L., Forget, B., Aubin, H., & Goldberg, S. R. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00113.x · Cited by 106
Cannabinoid receptor 1-expressing neurons in the nucleus accumbens
Winters, B. D., Krüger, J. M., Huang, X., Gallaher, Z. R., Ishikawa, M., Czaja, K., Krueger, J. M., Huang, Y. H., Schlüter, O. M., & Dong, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206303109 · Cited by 116
Gorzalka, B. B., Hill, M. N., & Chang, S. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.08.009 · Cited by 118
Gutierrez, T., Farthing, J. N., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706984 · Cited by 105
Scorticati, C., Fernández-Solari, J., De Laurentiis, A., Mohn, C., Prestifilippo, J. P., Lasaga, M., Seilicovich, A., Billi, S., Franchi, A., McCann, S. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404366101 · Cited by 106
Oka, S., Wakui, J., Ikeda, S., Yanagimoto, S., Kishimoto, S., Gokoh, M., Nasui, M., & Sugiura, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8796 · Cited by 110
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
Calandra, B., Portier, M., Kernéis, A., Delpech, M., Carillon, C., Fur, G. L., Ferrara, P., & Shire, D. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00349-0 · Cited by 108
Cabral, G. A., & Staab, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_13 · Cited by 130
Pini, L. A., Guerzoni, S., Cainazzo, M. M., Ferrari, A., Sarchielli, P., Tiraferri, I., Ciccarese, M., & Zappaterra, M. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-012-0490-1 · Cited by 107
Type-1 Cannabinoid Receptor Signaling in Neuronal Development
Gaffuri, A.-L., Ladarre, D., & Lenkei, Z. (2012) · Pharmacology · doi:10.1159/000339075 · Cited by 99
New Approaches to Antiglaucoma Therapy
Sugrue, M. F. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9608725 · Cited by 107
Ford, W. R., Honan, S. A., White, R., & Hiley, C. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704565 · Cited by 117
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus
Gamber, K. M., Macarthur, H., & Westfall, T. C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.017 · Cited by 107
Guindon, J., De Léan, A., & Beaulieu, P. (2006) · Pain · doi:10.1016/j.pain.2005.12.007 · Cited by 104
Russo, P., Strazzullo, P., Cappuccio, F. P., Trégouët, D., Lauria, F., Loguercio, M., Barba, G., Versiero, M., & Siani, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2523 · Cited by 108
Bátkai, S., Rajesh, M., Mukhopadhyay, P., Haskó, G., Liaudet, L., Cravatt, B. F., Csiszár, A., Ungvári, Z., & Pacher, P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00373.2007 · Cited by 109
Govaerts, S. J., Hermans, E., & Lambert, D. M. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.07.013 · Cited by 107
Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception
Palazzo, E., Marabese, I., de Novellis, V., Oliva, P., Rossi, F., Berrino, L., Rossi, F., & Maione, S. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00160-x · Cited by 113
Role of Cannabinoids in Multiple Sclerosis
Zajicek, J., & Apostu, V. I. (2011) · CNS Drugs · doi:10.2165/11539000-000000000-00000 · Cited by 118
Couch, D. G., Cook, H., Ortori, C., Barrett, D., Lund, J. N., & O’Sullivan, S. E. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz017 · Cited by 101
Breivogel, C. S., & Childers, S. R. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38906-2 · Cited by 105
Fried, P. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00203-i · Cited by 106
Vrablik, T. L., & Watts, J. L. (2013) · Molecular Reproduction and Development · doi:10.1002/mrd.22167 · Cited by 120
McCaw, E. A., Hu, H., Gomez, G. T., Hebb, A. L. O., Kelly, M. E. M., & Denovan‐Wright, E. M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04460.x · Cited by 119
Molina-Holgado, F., Molina-Holgado, E., & Guaza, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00851-5 · Cited by 107
Carroll, C. B., Zeissler, M. ‐., Hanemann, C. O., & Zajicek, J. P. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01248.x · Cited by 104
SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist
Portier, M., Rinaldi-Carmona, M., Pecceu, F., Combes, T., Poinot-Chazel, C., Calandra, B., Barth, F., Le Fur, G., & Casellas, P. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37993-5 · Cited by 104
Slavić, S., Lauer, D., Sommerfeld, M., Kemnitz, U. R., Grzesiak, A., Trappiel, M., Thöne‐Reineke, C., Baulmann, J., Paulis, L., Kappert, K., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1034-0 · Cited by 105
Targeting cannabinoid agonists for inflammatory and neuropathic pain
Cheng, Y., & Hitchcock, S. A. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.951 · Cited by 102
Cannabinoid signaling in health and disease
Lu, Y., & Anderson, H. D. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0346 · Cited by 101
Metadata
- Authors
- Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Lolait, Stephen J.
- Venue
- Nature
- Published
- 1990-08-09
- Volume
- 346
- Issue
- 6284
- Pages
- 561-564
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075894678
- Cited by
- 5,011
- References
- 20
- Citations by year
- 2026: 47 · 2025: 84 · 2024: 105 · 2023: 141 · 2022: 129 · 2021: 205 · 2020: 185 · 2019: 171 · 2018: 153 · 2017: 169 · 2016: 172 · 2015: 176 · 2014: 184 · 2013: 190 · 2012: 200
- FWCI
- 53.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, G protein-coupled receptors, cDNA cloning, receptor structure, adenylate cyclase inhibition, pertussis toxin sensitivity, cannabis, central nervous system effects, brain mRNA expression
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Base Sequence, Binding, Competitive, Cannabinoids, Cell Line, Cerebral Cortex, Cloning, Molecular, Colforsin, Kinetics, Molecular Sequence Data, Receptors, Drug, Transfection, Gene Library, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.